Factors affecting Salmonella-based combination immunotherapy for prevention of type 1 diabetes in non-obese diabetic mice

Faculty Pharmacy Year: 2018
Type of Publication: ZU Hosted Pages: 8008-8018
Authors:
Mohammed Ibrahim Huseni
Journal: VACCINE ELSEVIER Volume: 36
Keywords : Factors affecting Salmonella-based combination immunotherapy for prevention    
Abstract:
We previously reported the development of an oral vaccine for diabetes based on live attenuated Salmonella-expressing preproinsulin (PPI) as the autoantigen. When combined with host cell-expressed TGFβ, the vaccine prevented the onset of di
    
     
 
       

Author Related Publications

  • Mohammed Ibrahim Huseni, "Avian influenza: virology, diagnosis and surveillance", Future Medicine, 2013 More
  • Mohammed Ibrahim Huseni, "Endogenous IFNγ in chronic HCV genotype 4 patients treated with PEG-IFNα and ribavirin", JIDC, 2013 More
  • Mohammed Ibrahim Huseni, "Hydrazones of 2-aryl-quinoline-4-carboxylic acid hydrazides: synthesis and preliminary evaluation as antimicrobial agents", ELSEVIER, 2006 More
  • Mohammed Ibrahim Huseni, "Recombinant vaccines based on translocated effector proteins of Salmonella Pathogenicity Island 2.", ELSEVIER, 2007 More
  • Mohammed Ibrahim Huseni, "Biosynthesis of gold nanoparticles using Pseudomonas aeruginosa.", ELSEVIER, 2007 More

Department Related Publications

  • Hisham AbdelMonem AbdelHamid Abaas, "Reviving Furosemide as a Metallo-β-Lactamase Inhibitor against MDR Acinetobacter baumannii", Korean Society for Microbiology and Biotechnology, 2025 More
  • Nora Mohamed Mokhtar Mohamed Selem, "Reviving Furosemide as a Metallo-β-Lactamase Inhibitor against MDR Acinetobacter baumannii", Korean Society for Microbiology and Biotechnology, 2025 More
  • Wael Mohamed Ali Ali Abdelhakiem, "Reviving Furosemide as a Metallo-β-Lactamase Inhibitor against MDR Acinetobacter baumannii", Korean Society for Microbiology and Biotechnology, 2025 More
  • Galal Yehya Abdelreheem Metwally, "Design and synthesis of novel chloropyridazine hybrids as promising anticancer agents acting by apoptosis induction and PARP-1 inhibition through a molecular hybridization strategy", Royal Society of Chemistry, 2024 More
Tweet